Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Oracle, Salesforce dip among Thursday’s market cap stock movers

Thursday’s market has seen notable movements across a spectrum of stocks, with some of the largest companies experiencing declines, while others in the large-cap space are on the rise. Mega-cap stocks like Oracle Corp (NYSE:ORCL) and Salesforce Com (NYSE:CRM) have seen a downturn, while large-cap players such as MicroStrategy Inc (NASDAQ:MSTR) are bucking the trend with impressive gains. Here’s a look at some of the most significant stock movers of the day, from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200B+):

Oracle Corp (ORCL): -4.03%
Salesforce Com (CRM): -3.84%
Avago Technologies (NASDAQ:AVGO): -3.08%
Servicenow Inc (NYSE:NOW): -2.68%
Adobe Sys Inc (NASDAQ:ADBE): -2.21%

Large-Cap Stock Movers (Market Cap $10B-$200B):

Dell Inc (NYSE:DELL): -12.25%
Hewlett-pack (NYSE:HPQ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
MicroStrategy Inc (MSTR): +9.94%
Autodesk Inc (NASDAQ:ADSK): -8.59%
Nutanix Inc (NASDAQ:NTNX): Nutanix to Present at Upcoming Investor Conference; -7.81%
BeiGene (NASDAQ:BGNE): +7.31%
Reinvent Technology Partners Y (AUR): +7.27%
Li Auto Inc (NASDAQ:LI): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
IBIT NASDAQ (IBIT): +6.44%
FBTC NYSE (FBTC): +6.37%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

SVF Investment 3 (SYM): -35.87%
Iris Energy (IREN): +29.71%
Arrowhead Research Corp (NASDAQ:ARWR): +24.23%
Urban outfitters (NASDAQ:URBN): +18.31%
Hut 8 Mining PK (HUT): +16.5%
HCM Acquisition (MRNO): +16.17%
Good Works Acquisition (CIFR): +14.56%
MSTU (MSTU): +13.93%

Small-Cap Stock Movers (Market Cap $300M-$2B):

Advanced Photonix Inc (API): +33.97%
ETHU (ETHU): +18.79%
Golden Bull (BTBT): +18.45%
Fate Therap (NASDAQ:FATE): +18.28%
Kingsoft Cloud Holdings Ltd (KC): +17.42%
Immunome Inc (NASDAQ:IMNM): +16.83%
Wowo Ltd (MFH): -16.32%
Semler Scientifc (NASDAQ:SMLR): +16.06%
Applied Therapeutics Inc (NASDAQ:APLT): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com